Overview of the Proposed Reforms of the EU Merger Control Regime -
In October 2016, the European Commission launched a public consultation to continue the process of identifying possible areas of the EU Merger Regulation...more
12/5/2016
/ 28 U.S.C. § 1782 ,
Acquisitions ,
Arbitration ,
Chile ,
China ,
Competition ,
Defend Trade Secrets Act (DTSA) ,
EU ,
European Merger Control Regulation ,
Foreign Investment ,
Healthcare ,
Member State ,
Mergers ,
Shareholders ,
Statute of Limitations ,
Trade Secrets
Recently, the General Office of the State Council published the Guiding Opinions on Pilot Comprehensive Reform of Urban Public Hospitals, which took effect on 6 May 2015. The Guiding Opinions give directions for the ongoing...more
Chinese consumers have long complained about high drug prices. To address this problem, in 2000 the Chinese government adopted a price ceiling system for drugs. At that time, the medical insurance system and the drug bidding...more
The chairman of China’s National Health and Family Planning Commission (HFPC) highlighted potential reforms that would allow increased foreign investment in China’s medical services industry, as well as support the “two-child...more
China's National Development and Reform Commission (NDRC) recently outlined its latest efforts in the enforcement of the Anti-Monopoly Law and price supervision. This newsletter summarizes the noteworthy information NDRC...more
The China Food and Drug Administration recently published a draft regulation setting minimum standards for medical device distribution. The regulation sets forth requirements for procurement, delivery acceptance, storage,...more
The Chinese Government’s wide-ranging bribery and corruption investigation into the pharmaceutical industry takes a new turn every week. Media reports contain numerous incidents of purported whistleblowers making allegations...more
China’s Ministry of Human Resources and Social Security issued provisions that align closely with recent changes to the PRC Labor Contract Law in order to help standardize labor dispatch in the country. The draft calls for a...more
The Chinese government’s recent crackdown on alleged bribery and corruption of local officials by multinational pharmaceutical companies could signal a broad trend toward elevated scrutiny of all foreign corporations...more
McDermott Will & Emery is pleased to offer “Distribution in China – Legal Issues*,” a one-stop resource covering distribution in China, including:
The business models and legal structures most commonly used for...more
4/4/2013
/ Bribery ,
Business Taxes ,
China ,
Compliance ,
Contract Drafting ,
Covenant of Good Faith and Fair Dealing ,
Customs ,
Distributors ,
E-Commerce ,
Exports ,
Foreign Corrupt Practices Act (FCPA) ,
Foreign Investment ,
Franchises ,
Imports ,
Joint Venture ,
Price-Fixing ,
Private Equity ,
Retailers ,
Trademarks ,
UK Bribery Act ,
Unfair Competition ,
Wholesale
“Distribution in China – Legal Issues” is a four-part series. Part I discussed the business models and legal structures most commonly used for distribution in China. Part II looked at important issues to consider in the...more
McDermott Will & Emery has a strategic alliance with MWE China Law Offices, a separate law firm based in Shanghai.
"Distribution in China – Legal Issues” is a four-part series. Part I discussed the business models...more